| Symbol | IMMG |
|---|---|
| Name | IMMAGE BIOTHERAPEUTICS CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 20817 United States MD 10411 Motor City Dr. Suite 750 |
| Telephone | (443) 961-1185 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | US |
| Incorporated On | 2012 |
| Employees | — |
| Fiscal Year | 8/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | MaloneBailey, LLP; |
| Audit Status | AUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001564273 |
| Description | Immage Biotherapeutics is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting edge immunotherapy candidates. The company is in the process of developing novel key cancer immunotherapy candidates that can be licensed to the biotechnology and pharmaceutical industry, allowing them the opportunity to develop in vitro proven treatments. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: IMMAGE BIOTHERAPEUTICS CO.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: IMMAGE BIOTHERAPEUTICS CO.
Read more